Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Gilead R&D chief Norbert Bischofberger is leaving in surprise exit, CEO revamps top science jobs
8 years ago
Bitter board members at Arcturus head to legal office to vote on directors
8 years ago
Operations head Wyss exits Novartis, giving way to new structure and a string of promotions
8 years ago
Martin Shkreli sentenced to 7 years on felony fraud convictions
8 years ago
The underdog champion of Roche’s huge pRED group is out. John Reed is coming home to America
8 years ago
R&D
Deflating R&D claims, prosecutors say an impatient Martin Shkreli conducted bogus drug study in Cyprus
8 years ago
Judgment day is coming: Federal judge orders Martin Shkreli to forfeit a small fortune following felony convictions
8 years ago
Global CRO Parexel woos outsourcing veteran Jamie Macdonald to the helm
8 years ago
Outsourcing
Activist investor Alex Denner in the spotlight again as the Medicines Company shrinks its board
8 years ago
What's up at stealthy Calico Labs? AI star Daphne Koller makes an abrupt exit as top team shrinks
8 years ago
AI
Sentencing date looming, a federal judge's ruling could leave Martin Shkreli in prison for years to come
8 years ago
Novartis’ oncology research chief in China jumps to upstart EpimAb in Shanghai
8 years ago
China
Vertex CMO Jeffrey Chodakewitz is hitting the exit doors. What's next?
8 years ago
Top Pfizer research exec John Davis joins migration to biotech, lands at Magenta as CMO
8 years ago
Well, that got awkward. Arcturus fires back at ex-CEO Joe Payne
8 years ago
Taking on a big challenge, ex-Celgene CEO Bob Hugin readies a run for the Senate
8 years ago
Pharma
Ex-FDA commish Califf joins Cytokinetics’ board just months after big ALS flop
8 years ago
David Hung makes a quick, abrupt exit at Axovant after humiliating setbacks
8 years ago
CEO Eliot Forster leaves Immunocore as the UK biotech unicorn hunts cash
8 years ago
Peer Review
Secret meetings, mergers and a board putsch: Arcturus founder/CEO claims 4 board members conspired on his ouster
8 years ago
Hans Bishop gets a $287M payday as Juno execs see windfall fortunes — with a $922M payoff for Arch
8 years ago
Financing
Deals
RNA biotech Arcturus boots CEO Joseph Payne
8 years ago
Peer Review
Gene therapy pioneer James Wilson sounds an alarm on high-dose AAV studies following toxic reactions in monkeys
8 years ago
Cell/Gene Tx
Merck R&D chief Roger Perlmutter offers some heavyweight R&D glam to a little upstart biotech out to cure Duchenne MD
8 years ago
First page
Previous page
89
90
91
92
93
94
95
Next page
Last page